Join the club for FREE to access the whole archive and other member benefits.

Michael Kope

Co-Chief Executive Officer and Co-founder Underdog Pharmaceuticals

Established SENS Research Foundation in 2009 with Aubrey de Grey, and was its founding CEO, serving until 2019.

Received his J.D. from the University of Michigan in 1990. He has served as the University of Michigan’s Intellectual Property Counsel; Director of Corporate Development for Aviron/MedImmune, Inc.; and as CEO and officer of a number of biotechnology startups.

Visit website:

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Company Underdog Pharmaceuticals - Company developing simple and direct interventions targeting toxic forms of cholesterol for age-related diseases.

Mentioned in this Resource


Non-profit organization focused on transforming the way the world researches and treats age-related diseases

Michael Kope is also referenced in the following:


Quick summary of SENS’ latest research projects and other activities

Michael Kope News

Underdog pharmaceuticals secures $10m funding from Kizoo ventures

Longevity Technology - 23-Sep-2021

Funds to bring affordable and effective age-related therapies to the public